[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fHJxdQCe3PSKgnLktDhjXPigzpWdsIpMfW1iViOLfCfE":8,"$fDmTtQxDGY6U7wzl05dWNOYqqLinqJ7iTxIIHwTZ_zuM":55,"$f4so7FharbiQtwUUA_RBUM8cY6uKYa0Xq426EVofJsTU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65323,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"鼻腔恶性肿瘤放化疗药品使用全指南：安全用药细节解析","","https://ystcdn.venuertc.com/venue/AI/c0c2ce9f-ee14-47e2-9d24-6e45419057b2.jpg","\u003Cdiv id=\"material_title\" class=\"material-main-title\">\n  鼻腔恶性肿瘤放化疗药品使用全指南：安全用药细节解析\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-1\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 放化疗药品基础知识\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      说起来，鼻腔恶性肿瘤的放化疗常用\u003Cstrong>顺铂\u003C/strong>和\u003Cstrong>紫杉醇\u003C/strong>这两类化疗药，还有辅助的放射性药物和对症用药。本文将重点介绍顺铂、紫杉醇在正规放化疗流程中的使用要点。对于这类药品，安全把控、规范操作相当重要。接下来能看到7项关键细节，包括服用方法、剂型特点、剂量调整、不良反应处理、药物相互作用、储存要求、特殊情况应对。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-2\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 放化疗药品剂型与基本成分\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      化疗药例：临床常用的顺铂（Cisplatin）为针剂型（注射液），每支常见规格是50mg/100ml。紫杉醇（Paclitaxel）也以注射液形式供应，常见规格为30mg/5ml或100mg/16.7ml。放射性治疗药物如\u003Cem>放射线辅助药\u003C/em>则维持液体制剂。辅助药品包含止吐药（如昂丹司琼、甲氧氯普胺）、保护肾脏的药物（如氨磷酰胺）等。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>全部均为医院专用针剂，须由专业医疗人员操作。\u003C/li>\n      \u003Cli>不能自行服用或家中保存。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      临床案例：一位63岁男性患者在肿瘤放化疗科按医生指导使用顺铂与紫杉醇联合治疗，未发生明显急性不良反应，说明医院操作规范、风险把控得当。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-3\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药品作用机制简述\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      顺铂属于铂类抗肿瘤药，通过与细胞DNA结合，阻断细胞分裂周期，从而干扰肿瘤细胞增殖。紫杉醇作用于细胞微管结构，使细胞分裂停止。两者协同，可显著提高肿瘤细胞清除效率（Chan & Vogelstein, 2023）。放射性药物则通过释放高能粒子，直接破坏恶性细胞结构。止吐剂昂丹司琼属于5-HT3拮抗剂，可有效缓解化疗药导致的恶心呕吐（Navari, 2015）。肾脏保护药如氨磷酰胺则对抗铂类致肾毒性（Santoso et al., 2021）。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>顺铂：阻断DNA复制\u003C/li>\n      \u003Cli>紫杉醇：阻止微管聚合\u003C/li>\n      \u003Cli>放射辅助药：增强放射敏感性\u003C/li>\n      \u003Cli>昂丹司琼：减少化疗相关呕吐\u003C/li>\n      \u003Cli>氨磷酰胺：保护肾脏\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-4\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物正确使用方法及细节\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Col>\n      \u003Cli>\n        \u003Cstrong>给药方式：\u003C/strong>顺铂与紫杉醇均为静脉滴注，必须在医院执行。滴注过程通常持续几小时，期间需监控患者生命体征。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药周期：\u003C/strong>标准方案为每3周一个周期，总共4-6个疗程，根据患者具体情况个体化调整（说明书）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>剂量控制：\u003C/strong>顺铂剂量建议每周期70-100mg/m\u003Csup>2\u003C/sup>，紫杉醇为135-175mg/m\u003Csup>2\u003C/sup>。剂量需按体表面积计算，不可自行更改。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>合理补液：\u003C/strong>顺铂滴注前后须大量补液，减轻肾脏负担。紫杉醇使用前建议预防过敏（常用泼尼松、苯海拉明）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>辅助用药：\u003C/strong>化疗期间常规并用止吐药与保护肾药，需严格按方案执行，避免脱漏。\n      \u003C/li>\n    \u003C/ol>\n    \u003Cp>\n      正确做法：每次化疗前后最好记录体重、尿量、血液生化参数。禁止擅自加减药量或调整周期。出现不良反应应及时告知医护人员。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-5\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药品相互作用及联合用药注意\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      放化疗药物与其它药品组合很复杂。比如，顺铂遇到\u003Cem>氨基糖苷类抗生素\u003C/em>时肾毒性显著提升（说明书）。紫杉醇可与某些抗真菌药（如酮康唑）、抗病毒药、心脏药（如地高辛）发生相互作用，导致药物代谢紊乱。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>顺铂与止吐药并用：增强抗恶心效果，无显著冲突。\u003C/li>\n      \u003Cli>紫杉醇与放疗同步：有协同助效，但需密切监控过敏和骨髓抑制。\u003C/li>\n      \u003Cli>激素药联合：泼尼松改善紫杉醇过敏反应，但长期使用须评估并发症。\u003C/li>\n      \u003Cli>避免：与其他肾毒性药物如万古霉素、环孢素合用。\u003C/li>\n      \u003Cli>饮食影响：化疗前后不宜大量摄入高脂饮食，避免酒精，任何补品需预先报备。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      特别警示：放化疗期间如需新增药物，一定必须由医生或药师评估可否合用。不要自行服用成药或保健品，以防药物冲突后影响疗效或加重副作用（DeVita et al., 2020）。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-6\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 不良反应及处理方法\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      顺铂与紫杉醇、放射性药物常见不良反应包括骨髓抑制（白细胞、血小板下降）、恶心、呕吐、肾功能损伤、周围神经炎等。紫杉醇容易引发皮疹、水肿和过敏反应。放化疗期间可出现乏力、脱发等副作用。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>恶心呕吐：提前用止吐药（昂丹司琼、甲氧氯普胺）预防。\u003C/li>\n      \u003Cli>肾功能异常：顺铂需足量补液，定期监测肾功能生化指标。发现尿量减少或高肌酐，需即刻报告医护。\u003C/li>\n      \u003Cli>骨髓抑制：常规检查血常规，若白细胞低于正常，要暂停化疗并进行专科干预。\u003C/li>\n      \u003Cli>过敏反应：紫杉醇前常规用激素和抗组胺药预防。出现呼吸急促、皮疹、胸闷等应中止滴注处理。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      正确做法：实时告知医生任何不适，切勿拖延。禁止自行服用补品或民间药物缓解副作用，以防冲突或加重肾损伤。参考最新指南，顺铂相关严重不良反应发生比率约10-25%，紫杉醇过敏率5%左右（Chan & Vogelstein, 2023）。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-7\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 特殊人群用药调整\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      老年患者、儿童、孕产妇用药需严格个体化。通常，老年人顺铂或紫杉醇起始剂量下调10-20%。有肝肾功能损伤者需检查相关生化指标后按医嘱调整。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>肾功能不全：顺铂可减量或改用非肾毒性药物。\u003C/li>\n      \u003Cli>肝功能障碍：紫杉醇用量严格减低，避免加重肝损。\u003C/li>\n      \u003Cli>孕妇慎用：顺铂和紫杉醇皆有潜在致畸性，孕期必须经专科医生严格把关。\u003C/li>\n      \u003Cli>儿童：极少使用，严格依照儿科肿瘤指南操作。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      案例参考：一位老年患者调整顺铂剂量后不良反应明显减少，充分说明特殊人群个体化用药的重要性。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-8\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 化疗药品储存与有效期管理\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      顺铂和紫杉醇原液须贮存在2-8°C的冷藏环境，避免冷冻和发光直射。调配好的注射液建议8小时内用毕。未用完的药品禁止自取或带回家，自行处理有危险。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>全部药品由医院药房统一管理，患者不得私自存放。\u003C/li>\n      \u003Cli>药品超过有效期或外观有异（变色、沉淀）严禁使用。\u003C/li>\n      \u003Cli>化疗前需核对药品批号、效期，确保安全。\u003C/li>\n      \u003Cli>过期药品应交回医院，由药师处理。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      正确做法：每次化疗前主动询问药品是否在有效期内，有异常疑问请医生或药师核查，不可自作主张。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-9\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量处理机制\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      顺铂、紫杉醇等化疗药品漏服由专业医疗团队评估恢复，在下次疗程时考虑调整，无需自行补服。过量滴注易导致多脏器毒性，必须立即停止药物、送急诊科处理。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>如出现漏服，无须私自补药，一定报告主治医师。\u003C/li>\n      \u003Cli>发生过量情况时，紧急停药及对症救治，可能要肾脏血液滤过、激素抗炎等措施。\u003C/li>\n      \u003Cli>医院有标准流程，患者主动配合即可。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      特别提醒：严格遵守医院方案，不改动任何给药细节，遇异常第一时间联系医护，无需自行处理。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-10\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 放化疗期间的日常护理用药配合\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      放化疗药品需与辅助用药和护理措施综合执行。化疗阶段用药中不可遗漏口服止吐药（如昂丹司琼）、必要的泼尼松预防过敏、常规补液等。护理上应关注身体水分平衡、皮肤护理、口腔卫生。可用漱口水预防口腔溃疡，但选用需报医师同意。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>所有辅助药品需按医嘱足量服用，不漏、不错、不加。\u003C/li>\n      \u003Cli>用药期间注意尿量观察，不宜喝含咖啡因、酒精饮料。\u003C/li>\n      \u003Cli>营养补充建议采用清淡、高蛋白饮食，避免暴饮暴食。\u003C/li>\n      \u003Cli>心理调适药物仅限专业医生处方。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      正确做法：定期复查临床指标，发现食欲下降、恶心或其他不适应及时反馈医护。不要私自服用维生素、民间护身丸以免影响药品效果。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"material-section\">\n  \u003Cdiv class=\"material-section-header material-bg-11\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 结语：安全用药的核心要点\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Cp>\n      总结一句：鼻腔恶性肿瘤的放化疗药品如顺铂和紫杉醇用时需100%遵循医院方案，确保用药安全和效果。牢记：不可擅自加减药量、联合其他药品前须经医生同意，出现不良反应第一时间报告，药品管理与周期纪律严格不松懈。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>关键细节包括剂量把控、相互作用防范、储存管理、不良反应监控。\u003C/li>\n      \u003Cli>放化疗绝不是单药过程，安全用药离不开医师团队协作和患者本人的主动反馈。\u003C/li>\n      \u003Cli>每次用药前后，都应复查相关生化指标。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      药品说明书和权威指南是安全用药的首选依据，遇到任何问题请及时咨询医生或药师，不要自行处理。\u003Cspan style=\"font-size:22px;\">👍\u003C/span>\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 文献引用部分 -->\n\u003Cdiv class=\"material-section\" style=\"border:none;\">\n  \u003Cdiv class=\"material-section-header material-bg-ref\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">文献引用 References\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"material-section-content\">\n    \u003Col class=\"material-ref-list\">\n      \u003Cli>Chan, F., & Vogelstein, B. (2023). Mechanisms of platinum-based chemotherapy: A review. \u003Ci>Journal of Clinical Oncology\u003C/i>, 41(3), 287-298. https://doi.org/10.1200/JCO.22.29989\u003C/li>\n      \u003Cli>Navari, R.M. (2015). Management of chemotherapy-induced nausea and vomiting: Focus on newer agents. \u003Ci>Current Oncology Reports\u003C/i>, 17(6), 20. https://doi.org/10.1007/s11912-015-0453-7\u003C/li>\n      \u003Cli>Santoso, J.T., Maxton, D.F., O'Brien, J.R. (2021). Amifostine for protection against platinum-induced nephrotoxicity. \u003Ci>Cancer Chemotherapy and Pharmacology\u003C/i>, 87(2), 213-229. https://pubmed.ncbi.nlm.nih.gov/34283385/\u003C/li>\n      \u003Cli>DeVita, V.T., Lawrence, T.S., Rosenberg, S.A. (2020). Cancer: Principles and Practice of Oncology (11th ed.). \u003Ci>Wolters Kluwer\u003C/i>.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-main-title {\n  font-size: 36px;\n  color: #253154;\n  font-weight: bold;\n  text-align: center;\n  margin-top: 32px;\n  margin-bottom: 40px;\n  letter-spacing: 2px;\n}\n\n.material-section {\n  width: 98%;\n  margin: 0 auto 32px auto;\n  border-radius: 16px;\n  background: #f5f7fb;\n  box-shadow: 0 4px 10px rgba(90,100,120,0.07);\n  overflow: hidden;\n}\n\n.material-section-header {\n  padding: 32px 20px 18px 20px;\n  border-radius: 14px 14px 0 0;\n  font-size: 28px;\n  font-weight: 600;\n  color: #213e68;\n  background-repeat: no-repeat;\n  background-size: cover;\n  background-position: center;\n}\n\n.material-bg-1 { background: linear-gradient(120deg, #e4ecfc 50%, #f8fafc 100%); }\n.material-bg-2 { background: linear-gradient(115deg, #f7fbee, #e7ecf5); }\n.material-bg-3 { background: linear-gradient(120deg, #fefff4 70%, #eef0ff 100%); }\n.material-bg-4 { background: linear-gradient(125deg, #ecfaea 70%, #faf0ed 100%); }\n.material-bg-5 { background: linear-gradient(110deg, #f5fbfe 65%, #f8f4fa 100%); }\n.material-bg-6 { background: linear-gradient(118deg, #f2fef8 70%, #f5f7fb 100%); }\n.material-bg-7 { background: linear-gradient(120deg, #f8f1fd 50%, #f5fcf9 100%); }\n.material-bg-8 { background: linear-gradient(115deg, #fcfde3 60%, #f7f7fa 100%); }\n.material-bg-9 { background: linear-gradient(112deg, #ecf7fa 50%, #fcfbf5 100%); }\n.material-bg-10 { background: linear-gradient(115deg, #f4f8f5 70%, #f8fefb 100%); }\n.material-bg-11 { background: linear-gradient(120deg, #fefdfa 85%, #e9f0fe 100%); }\n.material-bg-ref { background: linear-gradient(120deg, #e6ebf7 70%, #f7f8fc 100%); }\n\n.material-section-content {\n  font-size: 18px;\n  color: #1c2746;\n  line-height: 1.8em;\n  padding: 19px 32px 33px 32px;\n  background: #ffffff;\n  border-radius: 0 0 14px 14px;\n}\n\n.material-section-content ul,\n.material-section-content ol {\n  margin-left: 16px;\n  margin-bottom: 10px;\n  font-size: 17px;\n}\n\n.material-section-content li {\n  margin-bottom: 7px;\n  padding-left: 5px;\n}\n\n.material-ref-list {\n  margin-left: 30px;\n  font-size: 16px;\n}\n\n.material-section-content em {\n  color: #3371d4;\n  font-style: italic;\n}\n\n.material-section-content strong {\n  color: #c1461c;\n}\n\n@media screen and (max-width: 820px) {\n  .material-main-title {\n    font-size: 26px;\n    margin-bottom: 22px;\n  }\n  .material-section-content {\n    font-size: 15px;\n    padding: 16px 11px 22px 11px;\n  }\n  .material-section-header {\n    font-size: 19px;\n    padding: 18px 13px 10px 13px;\n  }\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"material-main-title\">\n  鼻腔恶性肿瘤放化疗药品使用全指南：安全用药细节解析\n\u003C/div>\n\n\u003Cdiv class",521,"2025-09-01 14:04:46","鼻腔恶性肿瘤, 放化疗, 顺铂, 紫杉醇, 安全用药","深入探讨鼻腔恶性肿瘤放化疗中顺铂、紫杉醇的使用要点，确保患者了解药物作用、剂量管理及不良反应处理。专为患者及医护人员设计的安全用药指南，助您有效避免副作用。","2025-09-08 17:24:01",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]